Inventor · disambiguated record
David Fairman
Also filed as: FAIRMAN DAVID
8 granted patents·3 pending applications·6 citations·filing 2013–2023
79Inventor score
Files withMEDIMMUNE LTD11
Top patents by PatentIndex Score
11 records- 0185US10829557B2Anti-B7-H1 antibodies for treating tumorsMEDIMMUNE LTD·Filed 2019·Granted Nov 10, 2020·2 cites·9 claims
- 0276US10336823B2Anti-B7-H1 antibodies for treating tumorsMEDIMMUNE LTD·Filed 2014·Granted Jul 2, 2019·3 cites·18 claims
- 0376US2023242639A1Anti-par2 antibodies and uses thereofMEDIMMUNE LTD·Filed 2023·Application pending·0 cites
- 0471US11230584B2Glucagon/GLP-1 agonists for the treatment of obesityMEDIMMUNE LTD·Filed 2019·Granted Jan 25, 2022·0 cites·13 claims
- 0569US11827706B2Anti-B7-H1 antibodies for treating tumorsMEDIMMUNE LTD·Filed 2020·Granted Nov 28, 2023·0 cites·20 claims
- 0669US11591389B2Nucleic acids encoding anti-PAR2 antibodies and uses thereofMEDIMMUNE LTD·Filed 2020·Granted Feb 28, 2023·0 cites·20 claims
- 0768US2022098265A1Glucagon/glp-1 agonists for the treatment of obesityMEDIMMUNE LTD·Filed 2021·Application pending·0 cites
- 0866US9765130B2Glucagon/GLP-1 agonists for the treatment of obesityMEDIMMUNE LTD·Filed 2013·Granted Sep 19, 2017·1 cites·19 claims
- 0963US10836822B2Anti-PAR2 antibodies and uses thereofMEDIMMUNE LTD·Filed 2018·Granted Nov 17, 2020·0 cites·13 claims
- 1061US2024150469A1Anti-b7-h1 antibodies for treating tumorsMEDIMMUNE LTD·Filed 2023·Application pending·0 cites
- 1157US10556939B2Glucagon/GLP-1 agonists for the treatment of obesityMEDIMMUNE LTD·Filed 2017·Granted Feb 11, 2020·0 cites·3 claims
Join the waitlist — get patent alerts
Get an alert when David Fairman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →